Nurix Therapeutics
NRIX
NRIX
163 hedge funds and large institutions have $1.01B invested in Nurix Therapeutics in 2025 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 69 increasing their positions, 43 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
4% less funds holding
Funds holding: 170 → 163 (-7)
23% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 30
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
163
Holding in Top 10
1
Calls
$1.72M
Puts
$173K
Top Buyers
| 1 | +$37.7M | |
| 2 | +$9.9M | |
| 3 | +$9.45M | |
| 4 |
PA
Perceptive Advisors
New York
|
+$8.64M |
| 5 |
Morgan Stanley
New York
|
+$7.57M |
Top Sellers
| 1 | -$18.6M | |
| 2 | -$15.8M | |
| 3 | -$12.7M | |
| 4 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$8.51M |
| 5 |
SC
Samlyn Capital
New York
|
-$6.12M |